This is the authors' abstract. We don't add key points for this paper.
Herein we present the methodology for obtaining glycosyltransferase inhibitors, analogues of natural enzyme substrates of donor-type: UDP-glucose and UDP-galactose. The synthesis concerned glycoconjugates, nucleoside analogues containing an acyclic ribose mimetic linked to a uracil moiety in their structure. The biological activity of the synthesised compounds was determined on the basis of their ability to inhibit the model enzyme action of β-1,4-galactosyltransferase from bovine milk. The obtained results allowed to expand and supplement the existing library of synthetic compounds that are able to regulate the biological activity of enzymes from the GT class.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Komor et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: